BSF Enterprise Plc Stock

Equities

BSFA

GB00BHNBDQ51

Pharmaceuticals

Market Closed - London S.E. 11:35:26 2024-07-02 am EDT 5-day change 1st Jan Change
4.75 GBX 0.00% Intraday chart for BSF Enterprise Plc -13.64% -53.66%
Sales 2022 - Sales 2023 0.01 Capitalization 10.59M
Net income 2022 - Net income 2023 -1M EV / Sales 2022 -
Net cash position 2022 830K Net cash position 2023 2.16M EV / Sales 2023 651,360,609 x
P/E ratio 2022
-2.79 x
P/E ratio 2023
-6.46 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 41.12%
More Fundamentals * Assessed data
Dynamic Chart
1 week-13.64%
Current month-9.52%
3 months-26.92%
6 months-58.70%
Current year-53.66%
More quotes
1 week
4.50
Extreme 4.5
5.48
1 month
3.50
Extreme 3.5
6.45
Current year
3.50
Extreme 3.5
12.45
1 year
3.50
Extreme 3.5
14.84
3 years
3.50
Extreme 3.5
23.88
5 years
3.00
Extreme 3
23.88
10 years
3.00
Extreme 3
23.88
More quotes
Managers TitleAgeSince
Founder 68 18-09-04
Chief Executive Officer 52 -
Director of Finance/CFO 61 22-06-05
Members of the board TitleAgeSince
Founder 57 18-09-04
Founder 68 18-09-04
Director/Board Member 58 21-08-04
More insiders
Date Price Change Volume
24-07-02 4.75 0.00% 397,835
24-07-01 4.75 -9.52% 210,749
24-06-28 5.25 0.00% 84,628
24-06-27 5.25 -4.55% 280,138
24-06-26 5.5 0.00% 3,205

Delayed Quote London S.E., July 02, 2024 at 11:35 am EDT

More quotes
BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.
More about the company